| Known as |
Mephedrone |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT02294266 ↗1NCT02232789 ↗
|
| Known as |
4-methylephedrone |
ChEMBL registry synonym — accepted as the source's own label CHEMBL4094396 ↗
|
| Known as |
4-methylmethcathinone |
ChEMBL registry synonym — accepted as the source's own label CHEMBL4094396 ↗
|
| Known as |
4-mmc |
ChEMBL registry synonym — accepted as the source's own label CHEMBL4094396 ↗
|
| Known as |
J2.756.280I |
ChEMBL registry synonym — accepted as the source's own label CHEMBL4094396 ↗
|
| Known as |
M-cat |
ChEMBL registry synonym — accepted as the source's own label CHEMBL4094396 ↗
|
| Known as |
Meow meow |
ChEMBL registry synonym — accepted as the source's own label CHEMBL4094396 ↗
|
| Modality |
Small molecule |
“Mephedrone (4-MMC, mephedrone) is a synthetic cathinone derivative included in the class of new psychoactive substances.” PMID 32063845 ↗ Jan 2020
|
| Route |
Oral |
“Mephedrone 200 mg, single dose, oral administration” NCT02232789 ↗
|